Table 2 Multivariable Cox analyses of clinical features on OS and DFS in patients with T2DM.

From: Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus

Evaluated factors

Multivariable (OS)

Multivariable (DFS)

HR (95.0% CI)

P

HR(95.0% CI)

P

Age at diagnosis

 

0.003

 

0.013

≤ 55 years

1

 

1

 

> 55 years

1.302 (1.094–1.549)

 

1.247 (1.048–1.484)

 

BMI

 

0.000

 

0.000

< 25

1

 

1

 

25–30

1.280 (1.070–1.532)

 

1.300 (1.087–1.556)

 

≥ 30

1.696 (1.300–2.213)

 

1.753 (1.344–2.286)

 

Tumour size

 

0.000

 

0.000

≤ 2 cm

1

 

1

 

> 2 cm, ≤ 5 cm

1.261 (1.053–1.511)

 

1.259 (1.051–1.507)

 

> 5 cm

2.281 (1.602–3.247)

 

2.234 (1.569–3.182)

 

Uncertain

1.248 (0.897–1.736)

 

1.241 (0.892–1.726)

 

Lymph node metastasis

 

0.000

 

0.000

0

1

 

1

 

1–3

2.684 (2.158–3.338)

 

2.716 (2.184–3.376)

 

4–9

3.960 (3.072–5.105)

 

4.096 (3.178–5.280)

 

≥ 10

9.264 (7.339–11.695)

 

9.837 (7.782–12.433)

 

ER status

 

0.012

 

0.016

Negative

1

 

1

 

Positive

0.738 (0.563–0.967)

 

0.738 (0.563–0.967)

 

Unknown

 

 

PR status

 

0.025

 

0.017

Negative

1

 

1

 

Positive

0.745 (0.580–0.958)

 

0.730 (0.569–0.938)

 

Unknown

 

 

Ki-67

 

0.009

 

0.007

Low

1

 

1

 

High

1.255 (1.017–1.547)

 

1.285 (1.042–1.584)

 

Uncertain

 

 

Groups

 

0.000

 

0.000

Non-diabetes

1

 

1

 

Metformin

0.386 (0.248–0.601)

 

0.384 (0.247–0.598)

 

Insulin

1.307 (0.848–2.014)

 

1.205 (0.781–1.858)